The present invention relates to an isoquinoline compound represented by the following formula (I) or (II), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water adduct thereof, a hydrate thereof and a solvate thereof, as well as an agent for the prophylaxis and/or treatment of a disease caused by hyperreactivity of poly(ADP-ribose)polymerase, containing the compound, and a poly(ADP-ribose)polymerase inhibitor containing the compound. In addition, this compound is useful as an agent for the prophylaxis and/or treatment of cerebral infarction, particularly as an agent for the prophylaxis and/or treatment of acute cerebral infarction.
本发明涉及一种由以下式(I)或(II)表示的
异喹啉化合物,其光学活性形式,其药学上可接受的盐,其
水加合物,其
水合物和其溶剂化物,以及一种含有该化合物的用于预防和/或治疗由多聚(
ADP-
核糖)聚合酶过度反应引起的疾病的药剂,以及一种含有该化合物的多聚(
ADP-
核糖)聚合酶
抑制剂。此外,该化合物对于预防和/或治疗脑梗死非常有用,特别是对于预防和/或治疗急性脑梗死。